Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Onyx HealthcareROCO:6569 +0.55%75 Net Margin % is 14.62% as of Jun. 2026, which is 11% above its 10-year median of 13.18. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$136.25 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 83.86% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Onyx Healthcare's Net Income for the
three
months ended in Jun. 2026 was NT$63 Mil. Onyx Healthcare's Revenue for the
three
months ended in Jun. 2026 was NT$429 Mil. Therefore, Onyx Healthcare's net margin for the quarter that ended in Jun. 2026 was 14.62%.
The historical rank and industry rank for Onyx Healthcare's Net Margin % or its related term are showing as below:
ROCO:6569'
s Net Margin % Range Over the Past 10 Years
Min: 8.54 Med: 13.18 Max: 17.1
Current: 12.64
ROCO:6569's Net Margin % is ranked better than 83.86% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 2.91
vs ROCO:6569: 12.64
Onyx Healthcare (ROCO:6569) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Onyx Healthcare Net Margin % Related Terms
Onyx Healthcare Net Margin % Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, HQY: Net Margin % Comparison
For the Health Information Services subindustry, Onyx Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Net Margin % distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Healthcare (ROCO:6569) has a Net Margin % of 14.62% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Onyx Healthcare and its competitors. This is 11% above median its historical median of 13.18. Over the past decade, Onyx Healthcare's Net Margin % has ranged from 8.54 to 17.10. According to the industry distribution chart, Onyx Healthcare ranks #108 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is Onyx Healthcare's Net Margin % too high?
Onyx Healthcare's current Net Margin % of 14.62% is 11% above median its 10-year median of 13.18. Over the past 10 years, this metric has ranged from a low of 8.54 to a high of 17.10. The Healthcare Providers & Services industry median Net Margin % is 2.91. Onyx Healthcare's value of 14.62% is 402.4% above this industry median. Based on the distribution chart, Onyx Healthcare ranks #108 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #108 out of 669 companies for Net Margin %. This places Onyx Healthcare in the top 16% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.91. Onyx Healthcare's value of 14.62% is 402.4% above this benchmark. Historically, Onyx Healthcare's own Net Margin % has ranged from 8.54 to 17.10 over the past decade. While the company's 10-year median is 13.18 vs. the industry median of 2.91, Onyx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.91, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Net Margin % of 14.62% is 402.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Net Margin % is 14.62%, which is 11% above median its own 10-year median of 13.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$136.25, compared to a current price of NT$91.80 — trading 32.6% below its estimated fair value. The current Net Margin % is 14.62%, which is 11% above median its 10-year median of 13.18 and 402.4% above the Healthcare Providers & Services industry median of 2.91. Onyx Healthcare's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Net Margin % is 14.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$91.80 is trading 32.6% below its estimated GF Value™ of NT$136.25.
GuruFocus considers Onyx Healthcare to be Significantly Undervalued.
Key valuation signals for ROCO:6569:
Net Margin %: 14.62% (11% above median its 10-year median of 13.18)
GF Value™: NT$136.25 vs. price of NT$91.80 (32.6% below fair value)
Industry Position: 402.4% above the Healthcare Providers & Services median (#108 of 669)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score
Get the complete analysis for ROCO:6569
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
